Dr. Yeldandi is the Director of SHARE India and an infectious disease specialist with over 25 years of experience in transplant-specific infectious diseases, public health policy, infection prevention, and patient safety.
To learn more about SHARE India, please select the link below:
https://www.theshareindia.org/
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more
